Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
29710 | 181 | 43.0 | 94% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
27 | 3 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//AGR2 | 109777 |
2641 | 2 | EPITHELIAL MESENCHYMAL TRANSITION//EMT//SNAIL | 3501 |
29710 | 1 | DISABLED 2//DAB2IP//DOC 2 | 181 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DISABLED 2 | authKW | 3167876 | 14% | 72% | 26 |
2 | DAB2IP | authKW | 3140487 | 12% | 85% | 22 |
3 | DOC 2 | authKW | 1012225 | 3% | 100% | 6 |
4 | DISABLED 2 DAB2 | authKW | 976068 | 5% | 64% | 9 |
5 | DAB2 | authKW | 918484 | 8% | 39% | 14 |
6 | RASAL2 | authKW | 674817 | 2% | 100% | 4 |
7 | CELL POSITIONING ORGANIZATION | authKW | 337408 | 1% | 100% | 2 |
8 | OVARIAN CANC TUMOR CELL BIOL PROGRAMS | address | 337408 | 1% | 100% | 2 |
9 | P96 | authKW | 337408 | 1% | 100% | 2 |
10 | PROT SIGNALING DOMAINS | address | 319642 | 3% | 32% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 985 | 39% | 0% | 70 |
2 | Cell Biology | 840 | 35% | 0% | 64 |
3 | Biochemistry & Molecular Biology | 337 | 38% | 0% | 68 |
4 | Genetics & Heredity | 113 | 12% | 0% | 21 |
5 | Medicine, Research & Experimental | 39 | 7% | 0% | 12 |
6 | Developmental Biology | 39 | 3% | 0% | 6 |
7 | Biophysics | 27 | 6% | 0% | 10 |
8 | Gastroenterology & Hepatology | 7 | 3% | 0% | 5 |
9 | Hematology | 7 | 3% | 0% | 5 |
10 | Pathology | 5 | 2% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | OVARIAN CANC TUMOR CELL BIOL PROGRAMS | 337408 | 1% | 100% | 2 |
2 | PROT SIGNALING DOMAINS | 319642 | 3% | 32% | 6 |
3 | OVARIAN CANC PROGRAM | 272087 | 6% | 16% | 10 |
4 | INTEGRATED CELLULAR PONSES | 264050 | 3% | 26% | 6 |
5 | INTER PROGRAM VASC BIOL TRANSPLANT | 224938 | 1% | 67% | 2 |
6 | TONGJI CANC | 192799 | 2% | 29% | 4 |
7 | BEIJING CARDIOVASICULAR RECEPTORS | 168704 | 1% | 100% | 1 |
8 | BIOMED TECHNOL UOS BARI | 168704 | 1% | 100% | 1 |
9 | CANC BIOL NB4 | 168704 | 1% | 100% | 1 |
10 | DEV MOL BIOCHEM BIOL | 168704 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOGENE | 1821 | 8% | 0% | 14 |
2 | BMC DEVELOPMENTAL BIOLOGY | 1819 | 2% | 0% | 3 |
3 | ONCOTARGET | 1104 | 5% | 0% | 9 |
4 | FRONTIERS OF MEDICINE | 755 | 1% | 0% | 1 |
5 | NEOPLASIA | 397 | 1% | 0% | 2 |
6 | JOURNAL OF BIOLOGICAL CHEMISTRY | 340 | 10% | 0% | 18 |
7 | THORACIC CANCER | 327 | 1% | 0% | 1 |
8 | CELL DEATH & DISEASE | 283 | 1% | 0% | 2 |
9 | ADVANCES IN ENZYME REGULATION | 281 | 1% | 0% | 1 |
10 | CURRENT ATHEROSCLEROSIS REPORTS | 253 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DISABLED 2 | 3167876 | 14% | 72% | 26 | Search DISABLED+2 | Search DISABLED+2 |
2 | DAB2IP | 3140487 | 12% | 85% | 22 | Search DAB2IP | Search DAB2IP |
3 | DOC 2 | 1012225 | 3% | 100% | 6 | Search DOC+2 | Search DOC+2 |
4 | DISABLED 2 DAB2 | 976068 | 5% | 64% | 9 | Search DISABLED+2+DAB2 | Search DISABLED+2+DAB2 |
5 | DAB2 | 918484 | 8% | 39% | 14 | Search DAB2 | Search DAB2 |
6 | RASAL2 | 674817 | 2% | 100% | 4 | Search RASAL2 | Search RASAL2 |
7 | CELL POSITIONING ORGANIZATION | 337408 | 1% | 100% | 2 | Search CELL+POSITIONING+ORGANIZATION | Search CELL+POSITIONING+ORGANIZATION |
8 | P96 | 337408 | 1% | 100% | 2 | Search P96 | Search P96 |
9 | BEIJING FATTY CHICKEN | 303665 | 2% | 60% | 3 | Search BEIJING+FATTY+CHICKEN | Search BEIJING+FATTY+CHICKEN |
10 | HDAB2IP | 303665 | 2% | 60% | 3 | Search HDAB2IP | Search HDAB2IP |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FINKIELSTEIN, CV , CAPELLUTO, DGS , (2016) DISABLED-2: A MODULAR SCAFFOLD PROTEIN WITH MULTIFACETED FUNCTIONS IN SIGNALING.BIOESSAYS. VOL. 38. ISSUE . P. S45 -S55 | 58 | 44% | 0 |
2 | ZHANG, ZY , CHEN, YH , TANG, JJ , XIE, XM , (2014) FREQUENT LOSS EXPRESSION OF DAB2 AND PROMOTOR HYPERMETHYLATION IN HUMAN CANCERS: A META-ANALYSIS AND SYSTEMATIC REVIEW.PAKISTAN JOURNAL OF MEDICAL SCIENCES. VOL. 30. ISSUE 2. P. 432-437 | 22 | 85% | 6 |
3 | MOORE, R , CAI, KQ , TAO, WS , SMITH, ER , XU, XX , (2013) DIFFERENTIAL REQUIREMENT FOR DAB2 IN THE DEVELOPMENT OF EMBRYONIC AND EXTRA-EMBRYONIC TISSUES.BMC DEVELOPMENTAL BIOLOGY. VOL. 13. ISSUE . P. - | 33 | 52% | 4 |
4 | JACOBS, C , TUMATI, V , KAPUR, P , YAN, JS , XIE, XJ , HANNAN, R , HSIEH, JT , KIM, DWN , SAHA, D , (2015) PRETREATMENT BIOPSY ANALYSIS OF DAB2IP IDENTIFIES SUBPOPULATION OF HIGH-RISK PROSTATE CANCER PATIENTS WITH WORSE SURVIVAL FOLLOWING RADIATION THERAPY.CANCER MEDICINE. VOL. 4. ISSUE 12. P. 1844 -1852 | 22 | 63% | 0 |
5 | TONG, JH , NG, DC , CHAU, SL , SO, KK , LEUNG, PP , LEE, TL , LUNG, RW , CHAN, MW , CHAN, AW , LO, KW , ET AL (2010) PUTATIVE TUMOUR-SUPPRESSOR GENE DAB2 IS FREQUENTLY DOWN REGULATED BY PROMOTER HYPERMETHYLATION IN NASOPHARYNGEAL CARCINOMA.BMC CANCER. VOL. 10. ISSUE . P. - | 24 | 57% | 31 |
6 | ORLANDINI, M , NUCCIOTTI, S , GALVAGNI, F , BARDELLI, M , ROCCHIGIANI, M , PETRAGLIA, F , OLIVIERO, S , (2008) MORPHOGENESIS OF HUMAN ENDOTHELIAL CELLS IS INHIBITED BY DAB2 VIA SRC.FEBS LETTERS. VOL. 582. ISSUE 17. P. 2542-2548 | 23 | 64% | 4 |
7 | XIE, XM , ZHANG, ZY , YANG, LH , YANG, DL , TANG, N , ZHAO, HY , XU, HT , LI, QC , WANG, EH , (2013) ABERRANT HYPERMETHYLATION AND REDUCED EXPRESSION OF DISABLED-2 PROMOTE THE DEVELOPMENT OF LUNG CANCERS.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 43. ISSUE 5. P. 1636-1642 | 19 | 66% | 7 |
8 | LIU, S , ZHU, N , CHEN, H , (2012) EXPRESSION PATTERNS OF HUMAN DAB2IP PROTEIN IN FETAL TISSUES.BIOTECHNIC & HISTOCHEMISTRY. VOL. 87. ISSUE 5. P. 350-359 | 17 | 68% | 1 |
9 | KARAM, JA , SHARIAT, SF , HUANG, HY , PONG, RC , ASHFAQ, R , SHAPIRO, E , LOTAN, Y , SAGALOWSKY, AI , WU, XR , HSIEH, JT , (2007) DECREASED DOC-2/DAB2 EXPRESSION IN UROTHELIAL CARCINOMA OF THE BLADDER.CLINICAL CANCER RESEARCH. VOL. 13. ISSUE 15. P. 4400-4406 | 19 | 63% | 28 |
10 | LIU, L , XU, C , HSIEH, JT , GONG, JP , XIE, DX , (2016) DAB2IP IN CANCER.ONCOTARGET. VOL. 7. ISSUE 4. P. 3766 -3776 | 32 | 32% | 0 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 22795 | ASK1//PP5//PROTEIN PHOSPHATASE 5 |
2 | 10997 | REELIN//DAB1//REELER |
3 | 14085 | MEGALIN//CUBILIN//AMNIONLESS |
4 | 4295 | CLATHRIN//CLATHRIN COATED VESICLES//ADAPTIN |
5 | 34666 | ZNF703//C8ORF4//THYROID CANCER 1 |
6 | 4031 | RAS//RAS PROTEINS//ONCOGENIC RAS P21 |
7 | 6575 | UNCONVENTIONAL MYOSIN//MYOSIN VI//MYOSIN I |
8 | 18342 | SULFATIDE//BIOMED ANAL RADIOISOTOPE//SEMINOLIPID |
9 | 1117 | SMAD//SMAD4//TGF BETA |
10 | 9584 | SEROUS TUBAL INTRAEPITHELIAL CARCINOMA//FALLOPIAN TUBE//SEROUS CARCINOMA |